News


Other news

Biotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel Disease

By JLABS

Read full story
Other news

Cyclica CEO Naheed Kurji Says AI Could Create a New Paradigm for Drug Development

By JLABS

Read full story
Other news

Avicanna Completes 2nd Equity Financing & Welcomes New Strategic Shareholder

By JLABS

Read full story
Other news

Ground-breaking tech identifies cognitive diseases with high accuracy

By JLABS

Read full story
Other news

Ontario-developed technology for screening variant libraries comes of age

By JLABS

Read full story
Other news

BlueRock Therapeutics and Hootsuite Top the 2018 Narwhal List

By JLABS

Read full story
Other news

Alzheimer’s Drug One-Step Closer to Reality After Krembil Team Signs Major Development Deal

By JLABS

Read full story
Other news

Why weed tech is missing from CES 2018, even as the budding industry booms

By JLABS

Read full story
Other news

qīī Redefines the Oral Health Industry With Launch of Proprietary Tea Drinks

By JLABS

Read full story
Other news

Cyclica and Translatum Medicus inc (TMi) Announce Partnership to Advance Small Molecule Discovery for Age-Related Macular Degeneration

By JLABS

Read full story
Other news

It's been a big year for Tennessee science

By JLABS

Read full story
Other news

MedChart, Eve Medical part of HealthTech projects funded by $5.47 million from Ontario

By JLABS

Read full story
Other news

Servier and Treventis begin strategic research partnership in neurodegenerative diseases

By JLABS

Read full story